Hematology
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
12 Aug, 2020 | 02:20h | UTCCommentary: New guidelines for managing mucositis now available – University of Rochester Medical Center
Peripheral blood examination findings in SARS-CoV-2 infection
10 Aug, 2020 | 01:58h | UTC
Study: Bleeding and thrombotic manifestations of SARS-CoV-2 infection
7 Aug, 2020 | 03:16h | UTCCOVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection – Blood
Invited commentary: COVID-19 coagulopathy, thrombosis, and bleeding – Blood
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
4 Aug, 2020 | 03:01h | UTCCommentary: Ancient part of immune system may underpin severe COVID – Columbia University Irving Medical Center
Commentary on Twitter
A combination of clinical and molecular analyses supports an association between disorders of immune complement or coagulation with poor outcome in patients with SARS-CoV-2 infection, according to a @NatureMedicine paper. https://t.co/iIN12Bdw5H pic.twitter.com/H6AVXMyF3w
— Nature Research (@nresearchnews) August 3, 2020
Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
23 Jul, 2020 | 08:21h | UTC
[Abstract Only] Randomized trial: Carfilzomib, dexamethasone, and daratumumab vs. carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
22 Jul, 2020 | 02:11h | UTC
Thrombosis in hospitalized patients with COVID-19 in a New York City health system
21 Jul, 2020 | 09:21h | UTCThrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA
Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19
16 Jul, 2020 | 08:24h | UTCCommentary: Coagulation disorder in COVID-19 – The Lancet Haematology
Related Commentary on Twitter
NEW research—Results of a retrospective study including 380 patients with #COVID19 admitted to Wuhan Union Hospital explores haematological characteristics and related risk factors https://t.co/lbDVw5lFBC pic.twitter.com/0qlvHzfzhR
— The Lancet Haematology (@TheLancetHaem) July 11, 2020
ACC Consensus on management of anticoagulant-related bleeding
15 Jul, 2020 | 08:12h | UTCKey Points: ACC Consensus on Management of Anticoagulant-Related Bleeding
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
What do we know about convalescent plasma as a possible treatment for #COVID19? https://t.co/VZgPyW5HJy The @CochraneHaem living systematic review has now been updated, but uncertainty remains about the possible benefits & harms of #plasma. @CochraneUK's @SarahChapman30 explains. pic.twitter.com/9RQi6sDFV9
— Cochrane UK (@CochraneUK) July 10, 2020
[Preprint] Randomized Trial: Convalescent Plasma for COVID-19
6 Jul, 2020 | 08:47h | UTCConvalescent Plasma for COVID-19. A randomized clinical trial – medRxiv
Related Commentary on Twitter
Convalescent plasma for Covid-19: trial in Netherlands was stopped because median for neutralizing antibody titers for 79% of patients enrolled was similar to that of the plasma donors. They decided not much chance of benefit; might apply more generally ⬇️ https://t.co/NJogjnFOjK pic.twitter.com/yLNBRYmanl
— Hilda Bastian (@hildabast) July 5, 2020
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
30 Jun, 2020 | 07:41h | UTCCommentary: Researchers discover improved treatment for children with sickle cell anemia – Indiana University
Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients
29 Jun, 2020 | 09:03h | UTC
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
23 Jun, 2020 | 08:19h | UTC
Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk
18 Jun, 2020 | 09:12h | UTCCommentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press
Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19
18 Jun, 2020 | 09:03h | UTC
Thromboelastographic Results and Hypercoagulability Syndrome in Patients with Coronavirus Disease 2019 Who Are Critically Ill
16 Jun, 2020 | 07:58h | UTC
[Preprints Studies] Relationship Between Blood Group and Risk of Infection and Death in COVID-19
11 Jun, 2020 | 09:28h | UTCStudy 1: Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis – medRxiv AND Commentary: Blood type plays role in SARS-CoV-2 infection – News Medical
Study 2: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis – medRxiv AND Commentary: The Role Of Blood Type In Covid-19 Infection And Respiratory Failure – Forbes
Risk of Hospitalization with Hemorrhage Among Older Adults Taking Clarithromycin vs. Azithromycin and Direct Oral Anticoagulants
9 Jun, 2020 | 04:33h | UTC
CHEST Guideline: Prevention, Diagnosis and Treatment of Venous Thromboembolism in Patients with COVID-19
8 Jun, 2020 | 04:39h | UTC
Convalescent Plasma Therapy Shows Promise for Severe COVID-19 in Small Randomized Trial
4 Jun, 2020 | 05:08h | UTCEditorial: A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals – JAMA
Blood Vessel Attack Could Trigger Coronavirus’ Fatal ‘Second Phase’
3 Jun, 2020 | 03:56h | UTCBlood vessel attack could trigger coronavirus’ fatal ‘second phase’ – Science
Observational Study: Many Patients with Covid-19 in the ICU Develop Thromboembolism Despite Routine Prophylaxis
29 May, 2020 | 03:17h | UTC
Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis
29 May, 2020 | 03:03h | UTC“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”